Skip to main content

Riboflavin and ultraviolet illumination affects selected platelet mRNA transcript amounts differently.

Klein-Bosgoed C, Schubert P, Devine DV

Publication: Transfusion (2016) • Vol 56(9) • Page 2286-95PMID: 27443848View on PubMed

Purpose

This paper investigated the effects of Mirasol-treatment and room temperature storage on total RNA levels and levels of glycoprotein (GP)IIIa, GPIIb, GPIb, PLT factor (PF)4, osteonectin (SPARC), thrombospondin (TSP), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in platelets (Plts).

Conclusion

Total RNA levels declined linearly with storage and were 23% lower in Mirasol-treated than untreated Plts on Day 1. Levels of individual transcripts were significantly lower after Mirasol-treatment, but the magnitude of the effect was larger for long transcripts than short (>3 kb versus 1-2 kb) and 24 h post-treatment compared to 1 h post-treatment. During subsequent storage, levels of most transcripts declined more slowly in Mirasol-treated Plts than untreated Plts; although the difference was only significant for SPARC and GPIIIa.

Studies (1)

Purpose

This study investigated the effects of Mirasol-treatment and room temperature storage on total RNA levels and levels of GPIIIa, GPIIb, GPIb, PF4, SPARC, TSP, and GAPDH transcripts in Plts. After a 1 h rest, double apheresis Plts from an unspecified number of donors were split such that half of each specimen was mirasol-treated (50 umol/L riboflavin and UV illuminated) and the other half was saline-treated. Plts were removed 1, 4, 7, and 9 days after treatment, washed in EDTA-treated TRIS-saline (ETS), lysed in TRIzol, and stored at -80˚C. RNA was extracted using TRIzol and quantified by spectrophotometer and normalized to Plt count. Individual mRNAs were quantified by real-time PCR.

Summary of Findings

One day following Mirasol treatment, RNA levels were 23% lower than in untreated Plts. During subsequent storage, RNA levels in treated and untreated Plts declined linearly such that by Day 9 only 20% and 11% of original levels were found in untreated and Mirasol treated Plts, respectively. Levels of individual transcripts except GP1b were significantly lower 1 h after Mirasol treatment than prior to treatment (P<0.05, all). By 24 h, levels of all individual transcripts were significantly lower than prior to treatment (P<0.05, all) and were lower than at 1 h post-treatment, but the difference was only significant for GAPDH (P<0.01). The magnitude of the decrease in transcript levels was strongly positively correlated with transcript length (R2=0.85) with levels of transcripts >3 kb (GPIIIa, SPARC, and TSP) decreasing the most (<20% pretreatment) and levels of shorter transcripts like GAPDH and PF4 remaining at 40-80% of pretreatment levels. It was estimated there was an additional 14% loss after Mirasol treatment for every additional kb of transcript. While post-treatment levels of all transcripts were lower than in untreated controls, levels of most transcripts declined more slowly in Mirasol-treated Plts than untreated Plts during subsequent storage.  Interestingly, PF4 was only slightly affected by initial Mirasol treatment but declined more rapidly during subsequent storage. Although the rates of decline in Mirasol-treated and untreated Plts appeared to be different, only GPIIIa and SPARC had significantly longer half-life in Mirasol-treated Plts than untreated Plts (P<0.05). Decreasing the UV dose to 50% resulted in a larger percentage of GPIIIa and PF4 remaining after 24 h (23% versus 13%, P=0.05 and 67% versus 50%, not significant).

  • Biospecimens

    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
  • Platforms

    RNAReal-time qRT-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBlood processing method
    Mirasol (riboflavin and 100% UV illuminated) treated
    Mirasol (riboflavin and 50% UV illuminated) treated
    Untreated
    StorageTime at room temperature
    1 day
    1 h
    4 days
    7 days
    9 days
    Real-time qRT-PCR SpecificTargeted nucleic acid
    GAPDH
    GPIIIa
    GPIIb
    GPIb
    PF4
    SPARC
    TSP